Wellgistics Health Inc. Signs $105,000,000 Letter of Intent to Evaluate Potential Acquisition of Neuritek Therapeutics, Inc. which is Pioneering Innovative Therapies for Neurological and Psychiatric Disorders

Contributed by: ACCESS Newswire

Logo

Tags

Healthcare & Pharmaceutical

NASDAQ:WGRX

Wellgistics Health, Inc.

Company Update

More Like This

Neuraptive Therapeutics Inc. Receives Orphan Drug Designation for its Lead Development Asset

Neoclease receives Merck’s North American Advance Biotech Grant.

Merck Announces Neoclease as Winner of 2025 North American Advance Biotech Grant

Mölnlycke® Health Care announces US $15m investment in next-generation enzymatic therapeutics company MediWound Ltd

Merz Enters Asset Purchase Agreement With a US-Based Biotech Company

PR Newswire associated0

OrbusNeich Launches a High-Capacity Logistics Center in the Netherlands

Intrance Medical Systems Inc signs LOI purchase commitment for clinical trials with Parkinson's diseases patients

PR Newswire associated0

Charles River and Insightec Announce Strategic Collaboration to Advance Therapeutic Development Utilizing Focused Ultrasound in Neuroscience

EQT Life Sciences leads USD 56 million Series D financing in Neuros Medical to commercialize FDA-approved treatment for post-amputation pain